People: Merck & Co Inc (MRK.N)
25 Apr 2017
Mr. Robert M. Davis is Chief Financial Officer, Executive Vice President of Merck & Co., Inc., since April 23, 2014. Mr. Davis is responsible for the Company’s global financial organization, investor relations, corporate strategy and business development, global facilities, and the Company’s joint venture relationships. Prior to starting his employment with the Company, Mr. Davis served as Corporate Vice President and President, Medical Products of Baxter International, Inc. (“Baxter”), a healthcare company, a position he had held since October 2010. In that position, Mr. Davis was responsible for all aspects of commercial, R&D, quality, regulatory, manufacturing and supply chain functions. Prior to that position, Mr. Davis served as Corporate Vice President and President, Renal Division of Baxter in 2010 and had previously served as Baxter’s Corporate Vice President and Chief Financial Officer from 2006 to 2010.
|Total Annual Compensation, USD||3,605,760|
|Restricted Stock Awards, USD||2,103,990|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||1,609,250|
|Fiscal Year Total, USD||7,319,000|